AKT1 and breast cancer: Scutebarbatine A (SBT-A), a diterpene alkaloid, demonstrates strong inhibitory effects on breast cancer cells by inducing DNA damage, apoptosis, and ER stress through ROS generation, while also regulating the MAPK and EGFR/Akt signaling pathways [102].